Cervicitis: potentialities of alternative treatment
DOI: 10.32364/2618-8430-2021-4-3-225-228
L.V. Saprykina, D.M. Ibragimova, M.R. Narimanova
Pirogov Russian National Research Medical University, Moscow,
Russian Federation
Aim: to assess the efficacy of the alternative treatment for cervicitis in women of reproductive age and premenopausal women.
Patients and Methods: this pilot comparative study included 60 women of reproductive age and premenopausal women (25–45 years) with cervicitis who were divided into two groups. Group 1 women (n=30) received multi-component herbal preparation (Tukofitol cream) once daily for 20 days. Group 1 women were subdivided into two subgroups. In women of subgroup 1A (n=14), opportunistic flora in relevant titers was identified, and these women were prescribed systemic antibacterial treatment. In women of subgroup 1B, no opportunistic flora in relevant titers was identified, and these women were prescribed with multi-component herbal preparation only. Group 2 women (controls, n=30) were also subdivided into two subgroups. In subgroup 2A (n=16), women received systemic antibacterial treatment and Povidone Iodine vaginal to manage opportunistic flor a. In subgroup 2B (n=14), no opportunistic flora in relevant titers was identified, and a watch-and-wait approach was applied. Before treatment and 30 days, subjective symptoms typical for cervicitis were evaluated, laboratory tests and colposcopy were performed.
Results: two women from each group have withdrawn from the study. In group 1, more rapid improvement of cervicitis symptoms vs. group 2 (p<0.05) was reported. Moreover, no growth of opportunistic flora was more commonly seen in group 1 (100%) compared to group 2 (92.85%, p>0.05).
Conclusion: the improvement of subjective criteria and laboratory test results has demonstrated that treatment was effective in both groups. In the lack of opportunistic flora in relevant titers, multi-component herbal preparation as monotherapy can be prescribed to reduce symptoms of inflammation.
Keywords: cervicitis, inflammation of the cervix, Tukofitol, reproductive age, premenopausal age, treatment, diagnostics, colposcopy, o pportunistic microbes, sexually transmitted infections, monotherapy.
For citation: Saprykina L.V., Ibragimova D.M., Narimanova M.R. Cervicitis: potentialities of alternative treatment. Russian Journal of Woman and Child Health. 2021;4(3):225–228 (in Russ.). DOI: 10.32364/2618-8430-2021-4-3-225-228.
Acknowledgement
The technical edition is supported by LLC “Adonis”.
About the authors:
Lyudmila V. Saprykina — C. Sc. (Med.), assistant of the Department of Obstetrics & Gynecology, Pirogov Russian National Research Medical University; 1, Ostrovityanov str., Moscow, 117437, Russian Federation; ORCID iD 0000-0002-2931-0956.
Dzhamilya M. Ibragimova — C. Sc. (Med.), associate professor of the Department of Obstetrics & Gynecology, Pirogov Russian National Research Medical University; 1, Ostrovityanov str., Moscow, 117437, Russian Federation; ORCID iD 0000-0002-8738-868X.
Metanat R. Narimanova — C. Sc. (Med.), assistant of the Department of Obstetrics & Gynecology, Pirogov Russian National Research Medical University; 1, Ostrovityanov str., Moscow, 117437, Russian Federation; ORCID iD 0000-0003-0677-2952.
Contact information: Lyudmila V. Saprykina, e-mail: lioudsap@yandex.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 13.07.2021.
Revised 05.08.2021.
Accepted 30.08.2021.
2. Workowski K.A., Bolan G.A., Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1.
3. Taylor S.N. Cervicitis of unknown etiology. Curr Infect Dis Rep. 2014;16:409. doi: 10.1007/s11908-014-0409-x.
4. Мандрыкина Ж.А., Сапрыкина Л.В., Нариманова М.Р. Опыт применения активированной глицирризиновой кислоты в монотерапии воспалительных заболеваний шейки матки. РМЖ. Мать и дитя. 2019;2(3):249–252. [Mandrykina Zh.A., Saprykina L.V., Narimanova M.R. Our experience with activated glycyrrhizinic acid (AGA) as monotherapy for the inflammatory disease of cervix uteri. Russian Journal of Woman and Child Health. 2019;2(3):249–253. (in Russ.)]. DOI: 10.32364/2618-8430-2019-2-3-249-253.
5. Lacroix G., Gouyer V., Gottrand F., Desseyn J-L. The Cervicovaginal Mucus Barrier. Int J Mol Sci. 2020;21(21):8266. DOI: 10.3390/ijms21218266.
6. Ortiz-de la Tabla V., Gutiérrez F. Cervicitis: Etiology, diagnosis and treatment Enferm Infecc Microbiol Clin (Engl Ed). 2019;37(10):661–667. DOI: 10.1016/j.eimc.2018.12.004.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать